NCT05336448 (PocusAI-Crit) is a clinical trial in Critical Illness, sponsored by Hospital Garcia de Orta.

Who is sponsoring NCT05336448?

NCT05336448 is sponsored by Hospital Garcia de Orta.

What condition does NCT05336448 study?

NCT05336448 studies Critical Illness.

Is NCT05336448 still recruiting?

NCT05336448 is currently completed. Last updated 16 September 2022.

Last reviewed 2022-09-16 · How we verify

NCT05336448: PocusAI-Crit

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

POCUS AI in Critically Ill Patients

Completed Last updated 16 September 2022

What this trial tests

trial in Critical Illness in 99 participants. Completed in 11 June 2022.

Timeline

27 July 2021

Primary endpoint
29 May 2022

11 June 2022

Quick facts

Lead sponsor	Hospital Garcia de Orta
Status	Completed
Study type	OBSERVATIONAL
Enrollment	99
Start date	27 July 2021
Primary completion	29 May 2022
Estimated completion	11 June 2022
Sites	1 location across Portugal

Conditions studied

Critical Illness — all drugs for Critical Illness →

Sponsor

Hospital Garcia de Orta

Who can join

18 and older, any sex, with Critical Illness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective study that aims to assess the differences in point-of-care ultrasound assessment (POCUS) with portable and ultra-portable devices, using conventional vs artificial intelligence (AI) methodologies, performed by experienced vs inexperienced physicians, in critically ill patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Machine learning for the real-time assessment of left ventricular ejection fraction in critically ill patients: a bedside evaluation by novices and experts in echocardiography.
Varudo R, Gonzalez FA, Leote J, Martins C, et al · · 2022 · cited 21× · PMID 36517906 · DOI 10.1186/s13054-022-04269-6

Verify or expand the search:

Other recruiting trials for Critical Illness

Currently open trials in the same condition.

NCT06189924 — Exhaled Breath Condensate Analysis in Mechanically Ventilated Patients · recruiting
NCT07418242 — Prognostic Value of Novel Biomarkers on Adverse Renal Outcomes in High-Risk Cardiac Surgery Patients · recruiting
NCT07101640 — PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary Dysp · Phase 1, PHASE2 · recruiting
NCT07177183 — Low Serum Creatinine as a Predictor of Prolonged Mechanical Ventilation and Weaning Failure · NA · recruiting
NCT07369258 — Clinical Application of Listening to Music to Prevent Delirium in the Intensive Care Unit · NA · recruiting

Other Hospital Garcia de Orta trials

Trials by the same sponsor.

NCT05552521 — Diastolic Dysfunction in Septic Shock and Cardiomyopathy Genetic Variants · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05336448 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hospital Garcia de Orta
Last refreshed: 16 September 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05336448.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing